Trinity Biotech (TRIB) Stock Chart & Stock Price History → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free TRIB Stock Alerts $1.65 -0.01 (-0.60%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Trinity Biotech Stock Price Performance5 Day Performance-2.37%1 Month Performance-5.71%3 Month Performance-25.00%6 Month Performance-30.96%Year-To-Date Performance-23.08%1 Year Performance-62.91% Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. TRIB Stock Chart for Sunday, June, 2, 2024 TRIB Chart by TradingView Trinity Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.66$1.68+1.20%$1.79$1.6542,519 shs$12.80 million05/30/2024$1.62$1.66+2.47%$1.81$1.6433,989 shs$12.65 million05/29/2024$1.61$1.62+0.62%$1.62$1.621,089 shs$12.34 million05/28/2024$1.69$1.61-4.73%$1.65$1.609,921 shs$12.27 million05/27/2024$1.69$1.69$1.70$1.585,800 shs$12.88 million05/24/2024$1.63$1.61-1.23%$1.69$1.585,881 shs$12.27 million Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.56$1.63+4.49%$1.67$1.5831,003 shs$12.42 million05/22/2024$1.55$1.56+0.65%$1.65$1.5312,409 shs$11.89 million05/21/2024$1.58$1.55-1.90%$1.68$1.537,916 shs$11.81 million05/20/2024$1.58$1.58$1.74$1.5815,734 shs$12.04 million05/17/2024$1.58$1.58$1.61$1.563,798 shs$12.04 million05/16/2024$1.52$1.58+3.95%$1.63$1.5636,793 shs$12.04 million05/15/2024$1.52$1.52$1.55$1.5122,955 shs$11.58 million05/14/2024$1.58$1.52-3.80%$1.63$1.4930,683 shs$11.58 million05/13/2024$1.70$1.58-7.06%$2.08$1.55197,294 shs$12.04 million05/10/2024$1.65$1.66+0.61%$1.71$1.655,600 shs$12.65 million05/09/2024$1.70$1.65-2.94%$1.78$1.6514,330 shs$12.58 million05/08/2024$1.69$1.70+0.59%$1.75$1.6624,081 shs$12.96 million05/07/2024$1.77$1.69-4.52%$1.81$1.6619,953 shs$12.88 million05/06/2024$1.80$1.77-1.79%$1.84$1.7115,470 shs$13.49 million05/03/2024$1.68$1.80+7.27%$1.80$1.6613,876 shs$13.73 million05/02/2024$1.75$1.68-4.00%$1.87$1.6826,125 shs$12.80 million05/01/2024$1.82$1.75-3.85%$1.88$1.7520,031 shs$13.34 million04/30/2024$1.78$1.82+2.25%$1.82$1.786,714 shs$13.87 million04/29/2024$1.83$1.78-2.73%$1.97$1.7810,525 shs$13.56 million04/26/2024$1.83$1.83$1.84$1.814,235 shs$13.95 million04/25/2024$1.85$1.83-1.08%$1.94$1.8312,497 shs$13.95 million04/24/2024$1.85$1.85$1.91$1.8311,196 shs$14.10 million04/23/2024$1.84$1.85+0.54%$1.90$1.822,789 shs$14.10 million04/22/2024$1.81$1.84+1.92%$1.84$1.791,560 shs$14.02 million04/19/2024$1.80$1.79-0.56%$1.84$1.795,746 shs$13.64 million04/18/2024$1.83$1.80-1.64%$1.88$1.7922,890 shs$13.72 million04/17/2024$1.86$1.83-1.61%$1.83$1.823,052 shs$13.95 million04/16/2024$1.91$1.86-2.62%$1.92$1.8025,502 shs$14.17 million04/15/2024$1.86$1.91+2.69%$1.92$1.845,278 shs$14.55 million04/12/2024$1.83$1.90+3.83%$1.92$1.8513,691 shs$14.48 million04/11/2024$1.93$1.83-5.13%$1.91$1.8127,571 shs$13.95 million04/10/2024$1.93$1.93-0.05%$1.94$1.8635,873 shs$14.70 million04/09/2024$1.93$1.93$2.04$1.8874,986 shs$14.71 million04/08/2024$1.98$1.93-2.53%$2.02$1.9326,240 shs$14.71 millionThe Worst is Yet to Come… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.04/05/2024$2.00$1.98-1.02%$2.10$1.977,843 shs$15.09 million04/04/2024$2.03$2.00-1.39%$2.10$2.0013,645 shs$15.25 million04/03/2024$1.96$2.03+3.50%$2.03$1.989,738 shs$15.46 million04/02/2024$1.95$1.96+0.51%$1.97$1.948,397 shs$14.94 million04/01/2024$2.04$1.95-4.41%$2.03$1.957,885 shs$14.86 million03/29/2024$2.05$2.04-0.49%$2.04$1.9618,211 shs$15.55 million03/28/2024$1.98$2.05+3.54%$2.05$1.9618,209 shs$15.62 million03/27/2024$2.03$1.98-2.46%$2.12$1.9812,359 shs$15.09 million03/26/2024$2.11$2.03-3.79%$2.22$2.0023,335 shs$15.47 million03/25/2024$2.12$2.11-0.47%$2.21$2.1121,184 shs$16.08 million03/22/2024$2.15$2.12-1.40%$2.17$2.126,044 shs$16.15 million03/21/2024$2.20$2.15-2.27%$2.20$2.1242,710 shs$16.38 million03/20/2024$2.13$2.20+3.29%$2.25$2.123,988 shs$16.76 million03/19/2024$2.20$2.13-3.18%$2.25$2.1213,442 shs$16.23 million03/18/2024$2.24$2.20-1.79%$2.26$2.153,985 shs$16.76 million03/15/2024$2.20$2.26+2.73%$2.26$2.0912,940 shs$17.22 million03/14/2024$2.22$2.20-0.90%$2.24$2.1213,831 shs$16.76 million03/13/2024$2.27$2.22-2.20%$2.30$2.215,965 shs$16.92 million03/12/2024$2.18$2.27+4.13%$2.29$2.1717,604 shs$17.30 million03/11/2024$2.23$2.18-2.24%$2.22$2.171,800 shs$16.61 million03/08/2024$2.22$2.23+0.45%$2.34$2.1631,344 shs$16.99 million03/07/2024$2.16$2.22+2.78%$2.35$2.1646,639 shs$16.92 million03/06/2024$2.10$2.16+2.86%$2.48$2.0814,749 shs$16.46 million03/05/2024$2.15$2.10-2.33%$2.20$2.0810,946 shs$16.01 million03/04/2024$2.15$2.15$2.20$2.1114,281 shs$16.38 million03/01/2024$2.18$2.20+0.92%$2.25$2.154,256 shs$16.76 million02/29/2024$2.20$2.18-0.91%$2.25$2.1516,363 shs$16.61 million Related Companies: ARCA biopharma Stock Chart ImmuCell Stock Chart Aspira Women's Health Stock Chart OncoCyte Stock Chart Cardio Diagnostics Stock Chart Biomerica Stock Chart MyMD Pharmaceuticals Stock Chart Virax Biolabs Group Stock Chart Navidea Biopharmaceuticals Stock Chart IDEXX Laboratories Stock Chart Receive TRIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRIB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.